Vimarsana
Biggest News Aggregation in the World

Epic Plus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Epic Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Epic Plus Today - Breaking & Trending Today

Printweek - FCS Laser Mail gets sorted with Vantage install - Vimarsana News

Printweek - FCS Laser Mail gets sorted with Vantage install

Print and mail firm FCS Laser Mail has installed a brand-new BlueCrest Vantage MT5 FlexLine sorter at its Birmingham factory, allowing the company to take on trade sortation work.

Mitral Valve Disease Market Trends : is Expected to Attain USD 5.7 billion by 2031 , Claims AMR - Vimarsana News

Mitral Valve Disease Market Trends : is Expected to Attain USD 5.7 billion by 2031 , Claims AMR

The mitral valve disease market size was valued at $2.5 billion in 2021, and is estimated to reach $5.7 billion by 2031, growing at a CAGR of 8.8% from 2022 to 2031.Drivers-The rising incidence of mitral valve disorders and the advancement of cutting-edge technologies for treating such conditions stand as crucial tr...

Prosthetic Heart Valve Market is Projected to Grow at 7.5% - Vimarsana News

Prosthetic Heart Valve Market is Projected to Grow at 7.5%

Global demand for prosthetic heart valves surges with an aging population, regulatory assurance, surgical advances, and tech innovations....

Prosthetic Heart Valve Market is Projected to Grow at 7.5% CAGR, Reaching US$ 27,277.6 Million by 2033 | | Future Market Insights, Inc. - Vimarsana News

Prosthetic Heart Valve Market is Projected to Grow at 7.5% CAGR, Reaching US$ 27,277.6 Million by 2033 | | Future Market Insights, Inc.

NEWARK, Del, Oct. 29, 2023 (GLOBE NEWSWIRE) -- The global prosthetic heart valve market size is expected to increase significantly, reaching US$ 13,234.9 million by 2023. Sales of prosthetic heart valves are predicted

Abbott wins FDA nod for Epic Max stented tissue valve - Vimarsana News

Abbott wins FDA nod for Epic Max stented tissue valve

Abbott (NYSE:ABT) announced today that the FDA approved its Epic Max stented tissue valve for treating aortic regurgitation or stenosis.